Atlas Trials

Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors

Clinical trial NCT01634893 · COMPLETED

Trial details

NCT number
NCT01634893
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory or Relapsed Solid Tumors
Start date
2012-06-01
Primary completion
2015-12-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.